Mid Continent Capital’s iShares Biotechnology ETF IBB Stock Holding History

Mid Continent Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.26M	Sell	22,338 -360	-2%	-$43.2K	0.15%	107
2015 Q2	$2.79M	Sell	22,698 -270	-1%	-$32.3K	0.15%	116
2015 Q1	$2.63M	Buy	22,968 +1,275	+6%	+$141K	0.14%	118
2014 Q4	$2.19M	Sell	21,693 -90	-0.4%	-$8.75K	0.12%	126
2014 Q3	$1.99M	Hold	21,783	–	–	0.12%	133
2014 Q2	$1.87M	Sell	21,783 -240	-1%	-$18.9K	0.11%	143
2014 Q1	$1.74M	Sell	22,023 -27,330	-55%	-$2.28M	0.1%	137
2013 Q4	$3.73M	Sell	49,353 -3,660	-7%	-$260K	0.23%	92
2013 Q3	$3.7M	Sell	53,013 -375	-0.7%	-$24.6K	0.26%	90
2013 Q2	$3.09M	Buy	+53,388	New	+$3.09M	0.23%	90

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Mid Continent Capital's IBB Position: Q3 2015 in Review

Mid Continent Capital reduced its iShares Biotechnology ETF (IBB) stake by 1.6% in Q3 2015, selling an estimated $43.2K and leaving 22,338 shares worth $2.26M. The position accounts for 0.15% of the portfolio, ranked #107.

Mid Continent Capital first reported a position in IBB in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.73M in Q4 2013. 414 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

Mid Continent Capital held 22,338 shares of iShares Biotechnology ETF worth $2.26M as of Q3 2015.
Mid Continent Capital sold 360 iShares Biotechnology ETF shares in Q3 2015, an estimated $43.2K.
iShares Biotechnology ETF made up 0.15% of Mid Continent Capital's portfolio in Q3 2015, its #107 holding.
Mid Continent Capital first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's iShares Biotechnology ETF position peaked at $3.73M in Q4 2013.
414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.